Mice bearing syngeneic A20 B cell lymphoma tumors (60-90 mm3) were treated with vehicle, duvelisib, anti-PD-1, anti-PD-1 + duvelisib, anti-OX40, or anti-OX40 + duvelisib. This evidence concerns the gene RPL17 and B-cell non-Hodgkin lymphoma.